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Abstract
Background and the purpose of the study: Dual functional agents in which nitroaromatic or nitroheterocyclic
compounds are attached through a linker unit to mustards and aziridines have shown higher cytotoxicities than
the corresponding counterparts to both aerobic and hypoxic cells and enhanced radiosensitizing activity. In the
present investigation cytotoxicity and radiosensitizing activity of 2,4-dinitrobenzyl, 2,4-dinitrobenzoyl, and 2,
4-dinitrophenacetyl derivatives of 5-fluorouracil which was assumed to release cytotoxic active quinone methidide
and 5-fluorouracil under hypoxic conditions on HT-29 cell line under both aerobic and hypoxic conditions was
investigated.
Methods: 5-fluorouracil derivative X-XIII were prepared by the reaction of the corresponding di-nitro substituted
benzyl, benzoyl and phenacetyl halides with 5-fluorouracil protected at N-1 with di-t-butoxydicarbonate (BOC) in
dimethyl formamide (DMF) in the presence of the potassium carbonate followed by hydrolysis of the blocking
group by potassium carbonate in methanol. Cytotoxicity of fluorouracil VIII and tested compounds X-XIII against HT-29
cell line under both aerobic and hypoxic conditions after 48 hrs incubation were measured by determination of the
percent of the survival cells using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and percent
of the dead cells using propidium iodide(PI)-digitonine assay and results were used to calculate the corresponding IC50
values. Radiosensitization experiments were carried out by irradiation of the incubations with a
60Co source and
clonogenic assay was performed to determine the cell viabilities following treatment with the tested compounds and/
or radiation. Sensitization Enhancement Ratio (SER) of each tested compound was obtained from the radiation survival
curves in the absence and presence of each sensitizer for 37% survival respectively.
Results and major conclusion: Findings of the present study showed that alkylation or acylation of 5-fluorouracil
result in compounds which have little or no cytotoxicity and radiosensitizing activity under aerobic conditions, but
have high cytotoxicity and radiosensitizing effects under hypoxic conditions. Furthermore radiosensitizing activities of
compounds under hypoxic conditions increased by increase in their concentrations and SER of the tested 5-FU
derivatives at concentrations higher than 50 μmol were equal or higher than 1.6 which is the minimum effective SER
of a radiosensitizer in an in vitro assay.
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One of the most important reasoning for the resistance
of solid tumors to chemotherapy and radiotherapy is the
presence of hypoxic cells in these tumors due to insuffi-
cient blood supply. Oxygen as a radiosensitizer increases
the effects of radiation by the formation of free radicals
that damage DNA [1]. Nitroaromatic and nitrohetero-
cyclic compounds known as electron affinic compounds
act like oxygen in the hypoxic cells and increase the sen-
sitivity of these cells to radiation by formation of radical
anions through one electron reduction which is reversed
by oxygen in aerobic cells [2]. In the absence of radia-
tion, radiosensitizers are also toxic to hypoxic cells due
to the formation of the nitro radical anion and suppres-
sing intracellular sulfhydryl compounds which are radio-
protectors [3]. In the normal oxygenated cells in which
the initially reduced species can be readily re-oxidized
by molecular oxygen, the cytotoxicity of the radiosensiti-
zers has been attributed to the parent nitro compound
or its bioactivation by NADPH:quinine oxidoreductase
which can act as an oxygen insensitive reductase [4].
Several hybrid or dual functional agents have been
described in which nitroaromatic or nitroheterocyclic
compounds are attached through a linker unit to cyto-
toxic nitrogen mustards [2] and aziridine moieties [5]
which act as a leaving group. These compounds have
shown higher cytotoxicities and enhanced radiosensiti-
zing activity on both aerobic and hypoxic cells than the
corresponding counterparts [5]. In these compounds cel-
lular reduction of the nitro group to more electron dona-
ting species activate the nitrogen of the cytotoxic group by
the release of electron through the aromatic ring and gen-
erate reactive alkylating species[2]. Previously it was shown
that 3[3-(2,4-dinitro-phenylamino)-propyl]-5-fluoro-1 H-
pyrimidine-2,4-dione resulting from linkage of 2,4-
dinitrophenylamine through three carbon atoms with 5-
fluorouracil which is not a leaving group, under aerobic
conditions is not cytotoxic but is radiosensitizer [6].
In the present study, the cytotoxicity and radiosensitizing
activity of 2,4-dinitrobenzoyl, 2,4- and 3,5-dinitrobenzoyl
and 2,4-dinitrophenylacetyl derivatives of 5-fluorouracil
which was assumed to produce quinone methides and 5-
fluorouracil [7] by increase in the electron density of the
aromatic ring through reduction of the nitro to electron re-
leasing groups under both aerobic and anaerobic conditions
was investigated (Scheme 1).
Material and methods
Materials and instrumentation
5-Flourouracil, 2,4-dinitrobenzoic acid, 2,4-dinitrophenyl-
acetic acid, 3,5-dinitrobenzoyl chloride, 2,4-dinitrobenzyl
chloride, di-t-butoxydicarbonate (Boc)2O, thionyl chloride,
4-Dimethyl aminopyridine (4-DMAP), digitonine, and
other chemicals and solvents not listed here were from
Merck Chemical Co. (Germany). HT-29 Cells (Human
colon cancer cells) from Pasteur Institute (Iran), RPMI
1640 from Gibco (England), Fetal Bovine Serum (FBS),
Penicillin/streptomycin 100X, Trypsin-EDTA 10X and
Trypan blue from Biosera (England),MTT and PI from
Sigma (USA) were used in this study. Thin layer chroma-
tography was carried out using silica gel (Kieselgel 60,
230–400 mesh, Merck) to monitor the progress of reac-
tions. Melting points were determined on a MEL-270
Sibata melting point apparatus and are uncorrected.
1HNMR spectra were recorded on 500 MHz Bruker (Ger-
many), using DMSO-d6 or CDCl3 as solvent. Chemical
shifts (δ) are reported in ppm relative to TMS as internal
standard. Mass spectra were obtained on a Finningan
TSQ-70 instrument. Infrared spectra were recorded on a
Nicolet Magna IR- 550 spectrometer (USA). All com-
pounds were characterized by the analytical and spectral
data. 3,5-dinitrobenzoyl chloride and 2,4-dinitrobenzyl
chloride were commercially available and the known 2,4-
dinitrobenzoyl, and 2,4-dinitrophenylacetyl chloride were
prepared by the reported method [8] through the reaction
of the corresponding acids with thionyl chloride. Analytical
and spectroscopic data for the known compounds were
consistent with the reported literature values and data only
for new compounds are presented.
Chemistry
Preparation of compounds X-XIII
Synthesis of 3-(2,4-Dinitrobenzyl)-5-fluoropyrimidine-
2,4(1 H,3 H)-dione X:
A solution of 5-Fu-Boc IX (2.30 g, 10 mmol) prepared
by the reported method [9] in 30 ml of DMF, was treated
with K2CO3 (1.38 g, 10 mmol), KI (0.41 g, 2.5 mmol),
and 2,4-dinitrobezyl chloride (2.2 g, 10 mmol) and the
mixture was heated at 78°C for 4 hrs. The mixture was
then treated with water, acidified with HCl, and
extracted with ethyl acetate (3×50 ml) and the organic
layer was washed with cold water (5×30 ml). The or-
ganic phase was evaporated under reduced pressure and
the residue was dissolved in MeOH (30 ml) and treated
with K2CO3 (1.4 g, 5.1 mmol) and the reaction mixture
was stirred for 2 hrs at room temperature. After evapor-
ation of methanol under vacuum, the residue was
diluted with EtOAc (30 ml) and washed with cold water
(30 ml). The organic phase was dried over Na2SO4, eva-
porated under reduce pressure and the residue was puri-
fied by flash column chromatography (silica gel, hexane-
EtOAc, 70:30) to give 1.74 g (56%) of the compound X
as pale yellowish white color solid; mp: 252-254°C
(EtOAc, hexane); IR (KBr) : 3129, 1736, 1659, 1541,
1347 cm
-1;
1H NMR (500 MHz, DMSO-d6): 5.33
(s, 2 H, CH2), 7.63 (d, J=8.5 Hz, 1 H, H6 phenyl), 8.01.
(d, J=8.5,1 H, H-6 FU), 8.43 (dd, J=8.5, 2.5 Hz, 1 H, H5
phenyl), 8.79 (d, J=2.5 Hz 1 H, H3 phenyl); MS: 310
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Synthesis of 3-(2,4-dinitrobenzoyl)-5-fluoropyrimidine-
2,4(1H,3H)-dione XI, 3-(2-(2,4-dinitrophenyl)acetyl)-5-
fluoropyrimidine-2,4(1H,3H)-dione XII and 3-(3,5-dini-
trobenzoyl)-5-fluoropyrimidine-2,4(1H,3H)-dione XIII:
A mixture of 5-Fu-Boc IX (2.30 g, 10 mmol) [9] and
K2CO3 (1.3 g, 10 mmol) in 20 ml of CH3CN were stirred
for 30 min and the mixture then was added dropwise over
30 min to a well-stirred, ice-cold CH3CN (25 ml) solution
containing 10 mmol of the appropriate dinitrobenzene
acid chloride. The mixture was stirred for another one
hour at 0°C, filtered and washed with CH3CN (30 ml).
After evaporation of the solvent under reduced pressure,
the residue was crystallized from an appropriate solvent to
give pure compounds XI-XIII.
XI: As pale yellowish white color (73%); mp: 195-198°C
(EtOAc, hexane); IR (KBr): 3131, 1734, 1656, 1536,
1349 cm
-1;
1H NMR (500 MHz, DMSO-d6): 8.01 (d,
J=8.5 Hz, 1 H, H-6 FU), 8.69 (d, J=6.5 Hz, 1 H, H6
phenyl), 8.77 (dd, J=6.5, 2.5 Hz, 1 H, H5 phenyl), 8.91 (d,
J=2.5 Hz 1 H, H3 phenyl); MS : 324 (5%), 278 (20%), 277
(45%), 195(100%), 167 (26%), 130 (72%), 91 (42%), 75
(78%).
XII: As pale yellowish white color solid (57%), mp: 222-
225°C (EtOAc, hexane); IR (KBr): 3125, 1730, 1652, 1540,
1345 cm
-1; 1 H NMR (500 MHz, DMSO-d6): 3.35 (s, 2 H,
CH2), 8.03 (d, J=8.5 Hz, 1 H, H6 phenyl), 8.69 (d, J=6.5,
1 H, H-6 FU), 8.77 (dd, J=8.5, 2.5 Hz, 1 H, H5 phenyl),
8.91 (d, J=2.5 Hz 1 H, H3 phenyl); MS: 338 (8%), 292
(18%), 209 (100%), 181 (19%), 157(38%), 130 (70%), 91
(47%), 75 (74%).
XIII As pale yellowish white color solid, (67%), mp: 184-
187°C (EtOAc, hexane); IR (KBr): 3133, 1738, 1656, 1547,
1350 cm
-1;
1H NMR (500 MHz, DMSO-d6): 7.76 (d,
J=6.5 Hz, 1 H, H-6 FU), 9.15 (d, J=3.1 Hz, 2 H, H2, H6
phenyl), 9.25 (d, J=3.1 Hz 1 H, H4 phenyl); MS : 324 (6%),
278 (23%), 277 (40%), 195(100%), 167 (28%), 130 (70%), 91
(43%), 75 (75%).
Biology
Cell culture
Studies were carried out with HT-29 cells, originally derived
from human colorectal carcinoma, obtained from Pasteur
Institute of Iran. Cells were grown as an attached mono-
layer in RPMI 1640 supplemented with 10% fetal bovine
serum, penicillin (50 unit/ml), and streptomycin (50 μg/ml).
Cells were routinely grown in tissue culture flasks and kept
in a humidified atmosphere of 5% CO2 and 95% air at 37°C.
Determination of the cytotoxicity
The experiments were carried out in 96-well culture
dishes. HT-29 cells were seeded at the density of 10
4
cells/well. Compounds VIII and X- XIII were dissolved in
DMSO to a stock concentration of 50 mmol and stored
at -20°C. The stock solutions were diluted with culture
media to final concentrations of 6.75-400 μmol and added
to each well of dish. Culture mediums containing DMSO
in concentration equal to those which were used in incu-
bations treated with the tested compound served as con-
trol. Cell incubations were kept at 37°C for 48 hrs under
air by purging with 95% nitrogen and 5% CO2 or hypoxia
in sealed GasPak jar by using Anoximat (Netherland) and
an anaerobic chamber GasPak Jar (Merck, Germany) and
GasPak pluss (Merck, Germany) [10]. After removal of
the supernatant of the culture medium, wells were washed
with phosphate buffer saline (PBS), and the numbers of
live or dead cells were determined by MTT [11] and PI
[12] assays respectively as follows:
MTT assay
To each well of a 96 well plate was added 25 μl of MTT
(5 mg/ml in PBS) and incubated for 4 hrs at 37°C and then
100 μl of DMSO was added to dissolve the precipitated
formazan and its absorbance was read in Elisa reader at
550 nm and a background wavelength of 690 nm.
Survival was scored by the ratio of the absorbance of the
treated cells to untreated cells with the tested compounds
(control) and is expressed as percentage of the cell survival.
Cytotoxicity was assessed using cell survival curves in
which the percentages of cells that survive were plotted as
a function of concentration of tested compounds from
which the corresponding IC50 values were determined [11].
PI-digitonine assay
To each well of a 96 well plate was added 20 μlo fa
1.53 mmol solution of propidium iodide (PI) in PBS for
a final concentration of 30 μmol. After 60 min
Scheme 1 Proposed metabolic reduction of compounds X-XIII on the basis of reference 7.
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the dead cells was measured in a multi-well plate reader,
(BioTek, Synergy HT, USA) with 530-nm excitation and
645-nm emission filters. Then digitonine (600 nmol) was
added to each well to permeabilize all cells and label all
nuclei with PI and after 30 min incubation, the fluores-
cence intensity was measured again to obtain a value
corresponding to the total number of cells [12]. The per-
centage of dead cells was calculated as the proportion of
the initial fluorescence intensity over that corresponding
to the total number of cells [13]. Cytotoxicity was
assessed using cell survival curves in which the percen-
tages of cells that survive were plotted as a function of
the concentration of the tested compounds from which
the corresponding IC50 values were determined.
Radiosensitization experiments
Cell cultures were exposed to a range of concentrations
(0, 25, 50, 100 and 200 μmol) of each compound which
were lower than their corresponding IC50 values and
incubated in air or hypoxic condition at 37°C for 3 hrs.
Incubations were then irradiated with 5 different doses
of radiation (2, 4, 6, 8 and 12 Gy) at room temperature
at the dose rate of 1.67 Gy/min and Source Surface
Distance (SSD)=80 cm
2 by a
60Co source (Theratron
780 MDS – Nordion).
Clonogenic forming assay and cell survival curves
The medium of the cell cultures after treatment with the
tested compounds and/or irradiation were first separated
to remove the tested compounds, and washed with PBS.
Cells were seeded in 6-well plates at concentration of
5×10
3 cells per well and maintained at 37°C for 14 days.
The cells were then fixed in methanol, colonies which
Scheme 2 (a) 4-DMAP/CH3CN (b) 2,4-dinitrobenzyl chloride, K2CO3, KI, DMF (c) 2,4-dinitrobenzoyl chloride, K2CO3,C H 3CN
(d) 2,4-dinitrophenylacetyl chloride, K2CO3,C H 3CN (e) 3,5-dinitrobenzoyl chloride, K2CO3,C H 3CN.
Table 1 The IC50 values for 5-Fluorouracil VIII and tested
compounds X-XIII determined by MTT and PI assays on
human colon cancer (HT-29) cells under aerobic and
hypoxic conditions
IC50
VIII X XI XII XIII
*MTT
Aerobic 93±9 350±15 372±19 382±12 386±24
Hypoxic 89±7 308.9±19 301±16 302.1±20 350±17
**PI
Aerobic 88±7 345±14 380±20 393±18 379±9
Hypoxic 84±5 301±19 311±12 317±17 342±21x
Data points were obtained from three independent experiments, and the
standard deviations are given for each point (Mean±SD).
*: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
**: Propidium Iodide.
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taining more than 50 cells were scored. Sensitization En-
hancement Ratio (SER) were obtained from the survival
curves of irradiation in the presence and absence of the
tested compounds from the equation SER=D0 untreated
cells/D0 treated cells, where D0 values represent radi-
ation dose that leading to 37% cell survival [14].
Statistical analyses
For the cell survival and cell death assays each experi-
ment was repeated three times and results are mean±
SD of three independent experiments. Statistical analysis
was performed using SPSS11.0 for window (SPSS Inc,
USA) and descriptive statistics are shown as arithmetic
mean±standard deviation. Independent samples’ t-test
was used to investigate the differences between irradiated
and unirradiated cells treated with the tested compounds
and for comparing more than two groups One Way Ana-
lysis of Variance were performed and p value smaller than
0.05 was considered statistically significant.
Results and discussion
Direct acylation or alkylation of 5-fluorouracil usually give
a mixture of N-3, N-1, and N-1,3 substituted compounds
Figure 1 Clonogenic cell survival after 48 hrs incubation of HT-29 cell line with different concentration (6.25, 12.5, 25, 50, 100, 200, 400 μmol)
of 5-Fluorouracil VIII and tested compounds X-XIII under Aerobic (♦)a n dH y p o x i c( ■) conditions (Mean±SD), (†=P<0.05, ††=P<0.01).
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result in low yield and require chromatographic separation.
Therefore three-step sequences involving protection of the
N-1 position, acylation or alkylation at N-3 and removal of
the protecting group have been employed for the prepar-
ation of N-3 substituted 5-fluorouracils.
For the protection of N-1 position, the use of acyl
[16], benzyl [17], benzyloxymethyl [18], tetrahydropyra-
nyl [19], 2-(trimethylsilyl)ethoxymethyl (SEM) [20] and
di- t-butoxydicarbonate [9] groups have been described.
However introduction or removal of the most of these
groups are associated with some difficulties and in this
study BOC which is introduced and removed rapidly
and its uses is practical and economical was employed
for the protection of N-1 position of 5-FU [9]. Reaction
of the resulting N-1 protected 5-fluorouracil with di-
nitro substituted benzyl, benzoyl and phenacetyl halides
in DMF in the presence of the potassium carbonate
resulted in the formation of the corresponding N-3 de-
rivative which upon treatment with potassium carbonate
in methanol for removal of the protecting group gave
compounds X-XIII (Scheme 2).
Cytotoxicity of 5-Fu and tested compounds X-XIII
against HT-29 cell line under both aerobic and hypoxic
conditions after 48 hrs incubation, were determined by
measurement of the percent of the cell survival using
MTT assay [11] and the percent of the dead cell using
PI-digitonine assay [12]. The results of these assays were
used to obtain the IC50 values of the tested compounds
as well as the dose of the tested compounds at which
under aerobic conditions less than 10% growth inhib-
ition occurred (< IC10) as an appropriate dose for the
radiosensitization experiments. The cytotoxicity of the
compounds under both aerobic and hypoxic conditions
were similar after 3 hrs and within this period of time there
was no differential cytotoxicity at various concentrations.
However after 48 hrs the cytotoxicity of the tested com-
pounds were significantly different. Results of this study
showed that IC50 values measured by PI-digitonine assay
were not significantly different from those determined by
MTT assay (Table 1). While the tested compounds under
hypoxic conditions at different concentration reduced the
cell viability significantly (Figure 1 and Table 1), these com-
pounds were not cytotoxic under aerobic conditions and at
concentrations up to 100 μmol reduced the cell viability
only to less than 10%.
The cytotoxicity of 5-FU was not significantly different
under both aerobic and hypoxic conditions which is in
agreement with results of other investigations that N-
acylation or alkylation of 5-Fu reduces its cytotoxicity [15].
In contrast to a number of (O- and P- Nitrobenzyloxy-
carbonyl)-5-fluorouracils which have shown [7] equal cell
killings under both aerobic and hypoxic conditions, which
has been attributed to the instability and decomposition of
compounds, the cytotoxicity of the tested compounds of
this study under hypoxic in comparison with aerobic con-
ditions were higher indicating the possibility that under
this condition one electron reduction of these compounds
produce cytotoxic reactive intermediates. With exception
of 5-FU which under both conditions and compound XIII
which under hypoxic conditions showed highest and low-
est IC50 values respectively, IC50 values of other tested
compounds under either conditions were not significantly
different from each other indicating that they have similar
mechanism of action and might produce the same reactive
species. The low cytotoxicity of compound XIII could be
attributed to the presence of the nitro groups in the meta
position which in contrast to ortho positions after one
electron reduction does not produce reactive quinone
methiodide species and 5-FU.
Radiosensitization experiments was carried out under
conditions identical to the cytotoxicity measurement using
MTT assays by incubating HT-29 cells with compounds
under hypoxic and aerobic conditions at 37°C. After 3 hrs
where none of the compounds had shown significant cyto-
totoxicity, cells were irradiated with a
60Co source.
Table 2 Sensitizing Enhancement Ratios (SER) of different
concentrations (25, 50, 100, 200 μmol) of 5-Fluorouracil
VIII and tested compounds X-XIII on human colon cancer
(HT-29) cells upon exposure to different doses of
radiation(0, 2, 4, 8 and 12 Gy) under aerobic and hypoxic
conditions
Compound Concentration
(μmole)
SER
Hypoxic Aerobic
VIII 25 1.04 ± 0.04 1.09 ± 0.06
50 1.18 ± 0.11 1.12 ± 0.09
100 1.20 ± 0.12 1.16 ± 0.10
200 1.29 ± 0.10 1.21 ± 0.15
X 25 1.20 ± 0.12 1.10 ± 0.10
50 1.51 ± 0.09 1.16 ± 0.11
100 1.78 ± 0.15 1.24 ± 0.14
200 2.23 ± 0.21 1.29 ± 0.12
XI 25 1.30 ± 0.18 1.11 ± 0.08
50 1.57 ± 0.12 1.21 ± 0.16
100 1.85 ± 0.16 1.23 ± 0.10
200 2.39 ± 0.10 1.35 ± 0.17
XII 25 1.16 ± 0.14 1.10 ± 0.09
50 1.37 ± 0.18 1.15 ± 0.10
100 1.73 ± 0.11 1.26 ± 0.15
200 2.28 ± 0.21 1.33 ± 0.13
XIII 25 1.14 ± 0.09 1.07 ± 0.10
50 1.18 ± 0.14 1.13 ± 0.09
100 1.22 ± 0.23 1.18 ± 0.14
200 1.37 ± 0.15 1.25 ± 0.11
Means ± SD, each set of experiments was performed in triplicates.
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http://www.darujps.com/content/20/1/3Figure 2 Clonogenic cell survival of HT-29 cells upon exposure to different dose of Gamma-radiation (2, 4, 6, 8 and 12 Gy) after
incubation with different concentration (25, 50, 100 and 200 μmol) of 5-Fluorouracil VIII and tested compounds X-XIII under Aerobic
condition. Data points were obtained from three independent experiments, and the standard deviations are given for each point. (Mean±SD,
each set of experiments was performed in triplicates).
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http://www.darujps.com/content/20/1/3Figure 3 Clonogenic cell survival of HT-29 cells upon exposure to different dose of Gamma-radiation (2, 4, 6, 8 and 12 Gy) after
incubation with different concentration (25, 50, 100 and 200 μmol) of 5-Fluorouracil VIII and tested compounds X-XIII under Hypoxic
condition. Data points were obtained from three independent experiments, and the standard deviations are given for each point. (Mean±SD,
each set of experiments was performed in triplicates).
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through measurement of the cell growth inhibition using
colony formation [13] and the clonogenic cells was deter-
mined by staining with crystal violet and counting on Dis-
secting microscope. Results are presented in terms of
Sensitization Enhancement Ratio (SER) which were
obtained from the survival curves of irradiation in the
presence and absence of the tested compounds from the
equation SER=D0 untreated cells/D0 treated cells, where
D0 values represent radiation dose that leads to 37% cell
survival [21].
A comparison of the sensitizer enhancement ratio values
of the tested compounds (Table 2) revealed that under aer-
obic condition none of the compounds and under hypoxia
5-fluorouracil VIII and its 3,5-dinitrophenyl derivative XIII
had no radiosensitizing activity.
As it is shown in Figures 2 and 3 cells viability was
reduced dose dependently by irradiation which was sig-
nificant in the presence of the compounds X-XII under
hypoxic conditions. Radiosensitizing activities of these
compounds increased by increase in their concentrations
and at concentrations higher than 50 were equal or
higher than 1.6 which is the minimum effective SER [22]
of a radiosensitizer in an in vitro assay.
Conclusion
The present study showed that alkylation or acylation of
5-fluorouracil, results in compounds which have little or
no cytotoxicity and radiosensitizing activity on aerobic
cells but are toxic and radiosensitizer on hypoxic cells
and their uses may be advantageous in adjunct cancer
treatment by radiotherapy.
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